February 2nd
Clare Murphy, Chief Executive of BPAS
“We welcome all moves to improve women’s access to HRT medications and are pleased women’s experiences are finally being more widely recognised. Pharmacy access and advice from a trained professional may well be the preferred option for some women so this is a really positive step – our concern would be that these are products are affordably priced when they come to market.”
ENDS
For further information, please contact Katherine O’Brien, BPAS Associate Director of Campaigns and Communications, on katherine.o’brien@bpas.org or 07881 265276.
About BPAS
BPAS is a charity that sees over 100,000 women a year for reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception at clinics across Great Britain. It supports and advocates for reproductive choice. BPAS also runs the Centre for Reproductive Research and Communication, which seeks to develop and deliver a research agenda that furthers women’s access to evidence-based reproductive healthcare, driven by an understanding of women’s perspectives and needs. You can find out more here: https://www.bpas.org/get-involved/centre-for-reproductive-research-communication/
